MedTrace Logo

RCT Iron Supplementation and Malaria Chemoprophylaxis for Prevention of Severe Anemia and Malaria in Tanzanian Infants

NCT00497471 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 832

Last updated 2007-07-06

No results posted yet for this study

Summary

The purpose of this trial is to evaluate the efficacy of weekly iron supplementation and the efficacy of malaria chemoprophylaxis from 2 to 12 months of age in infants living in an area of intense and perennial malaria transmission

Conditions

Interventions

DRUG

Deltaprim (3.125 mg pyrimethamine plus 25 mg dapsone)

DRUG

iron (2 mg/kg/daily)

Sponsors & Collaborators

  • Agencia Española de Cooperación Internacional

    collaborator OTHER

  • World Health Organization

    collaborator OTHER

  • Hospital Clinic of Barcelona

    lead OTHER

Principal Investigators

  • Clara Menendez, MD, PhD · Centre for International Health, Hospital Clinic / Universitat Barcelona

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
1 Day
Max Age
1 Day
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1995-02-28
Completion
1999-07-31

Countries

  • Tanzania

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00497471 on ClinicalTrials.gov